C
ancer of the cervix is the third most common malignancy of the female reproductive system. 1 The American Cancer Society estimates that 11,150 women will be diagnosed with and 3670 women will die from cervical cancer in 2007. 2 Data from the Surveillance, Epidemiology, and End Results (SEER) Program have indicated that, whereas the 5-five year relative survival rates for cervical cancer have increased from 1975 to 2002 for all women (from 69.1% to 73.5%), survival rates remain lower for African-American (AA) women compared with white women. 3 During the period from 1996 to 2002, the relative survival rates were 75% and 67% for white women and AA women, respectively. 1 Racial differences in cervical cancer have been attributed to several factors, including stage at presentation, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] treatment differences, 4, 5, 8, 10, 14, 15 comorbid conditions, 14 and SES. 6, 7, 14, [16] [17] [18] [19] [20] [21] [22] [23] Unlike information on stage and treatment, however, databases used by public health researchers generally do not include information on individual SES. SES has been described in the cervical cancer literature using various combinations of measures, including poverty level, occupation, educational level, and insurance status. In addition, SES was defined in several studies using the United States Census at the neighborhood (census tract level) or zip code level as a proxy for individual SES. 7, 14, 16, 18, [20] [21] [22] In this regard, Krieger et al. designed the Public Health Disparities Geocoding Project to determine which specific measures of socioeconomic position (education, income, occupation, poverty level) and which geographic level would be most useful for health surveillance and research. [24] [25] [26] In their study on mortality rates and cancer incidence using SEER data, they observed that data based on census tract (average population, 4000) or on census block group (average population, 1000) performed similarly for all outcomes, including external validity, robustness, completeness, and user friendliness. However, the use of data at the United States Postal Service zip code level (average population 30,000) failed in some tests of external validity. 24 In the current study, we used data from the Metropolitan Detroit Cancer Surveillance System (MDCSS) to determine whether SES had an effect on the observed difference in survival among AA women and white women with cervical cancer. On the basis of methods reported by Krieger et al., 27 using census tract level data, we defined an SES variable by using information on education, occupation, and poverty as a proxy for individual SES status. This model offers a more inclusive method of defining SES than has been used in other studies that investigated the effect of SES on the survival of women with cervical cancer. 6, 7, 14, [16] [17] [18] [19] [20] [21] [22] [23] 
MATERIALS AND METHODS

Study Population
The study population consisted of women diagnosed with a first primary invasive cancer of the cervix uteri (International Classification of Diseases for Oncology codes C53.0-53.1 and 53.8-53.9). 28 Women were identified from 1988 to 1992 from the MDCSS, which allowed for a 10-year follow-up through 2002. The SEER Program of the National Cancer Institute reports cancer incidence and survival data on approximately 26% of the United States population. It was initiated in 1973, with Detroit as 1 of 7 founding members, and now consists of 17 registries throughout the United States. 29 From January 1, 1988 to December 31, 1992 , there were 1073 incident cases of female invasive cervical cancer diagnosed in the Detroit metropolitan area: Seven hundred twentyseven cases (62%) were classified in the SEER registry as white, and 346 cases (29.5%) were classified as AA. Racial designations of other (n 5 13), including American Indian, Chinese, Filipino, Korean, Asian Indian, and Laotian, or unknown (n 5 17), were not included because of the lack of sufficient numbers. In total, 20 women (2%) were excluded from the analysis, because they had tumors with nonspecific histology (neoplasm malignant; tumor cells malignant; or carcinoma undifferentiated, not otherwise specified [NOS] ). Another 17 women (1.7%) were excluded if they had a rare histology (carcinoma, anaplastic, NOS; basal cell carcinoma, NOS; neuroendocrine carcinoma; leiomyosarcoma; mullerian mixed tumor; carcinosarcoma; and mesonephroma, malignant). After these exclusions, the final sample size was 1036 women.
Definition of Variables Tumor characteristics
Tumor stage was defined according to the International Federation of Gynecology and Obstetrics (FIGO) staging system as stage I, IIA, IIB, III, IV, or unknown. Women with stage IIB cervical cancer are considered to have locally advanced disease and, unlike women with stage IIA disease, are treated with primary chemotherapy and radiation. 30 Tumor grade was classified as well differentiated, moderately differentiated, poorly differentiated, undifferentiated, or unknown. Lymph node involvement was classified as negative, positive, or unknown. Histology was categorized as squamous cell carcinoma (SCC), adenocarcinoma, or adenosquamous carcinoma. Tumor size was divided into 4 categories: 7 mm, from 8 mm to 4 cm, >4 cm, or unknown.
Demographic characteristics
Marital status at diagnosis was defined as married, unknown, or other (single, separated, divorced, or widowed). Race was classified as AA or white. Age at diagnosis was categorized as <50 years or 50 years.
Treatment
Surgery and radiation therapy were categorized into a variable that was labeled ''first course of cancerdirected treatment.'' Surgery was categorized as no cancer-directed surgery, local surgery only, simple hysterectomy, radical hysterectomy, or unknown. Local surgery included local surgical excision, excisional biopsy, trachelectomy, amputation of cervix or cervical stump, laser surgery with pathology specimen, or conization. Surgical therapy for preinvasive disease, fertility preservation (cryosurgery, laser surgery, and dilation and curettage), staging evaluation for debulking (pelvic exenteration, surgery of regional and/or distant sites only), and information on surgery that was nonspecific (hysterectomy, NOS or surgery, NOS) was excluded. The data on surgery were categorized further as either no surgery or surgery of any type. Radiation therapy was classified as none or refused, external beam radiation therapy alone, radioactive implants or isotopes with or without external beam radiation therapy, or radiation, NOS or planned radiotherapy. Only 2 women refused radiation therapy and were included with the patients who did not receive any radiation. Like the surgery variable, radiation therapy was categorized further into either no radiation therapy received or radiation therapy of any type. We used information on surgery and radiation therapy to create a first course of cancer-directed treatment variable that consisted of the following 5 categories: neither surgery nor radiation, surgery only, radiation therapy only, surgery and radiation therapy, and unknown. Chemotherapy use was classified as chemotherapy that was either administered or planned, either not administered or refused, or unknown.
SES
A census tract number was obtained from the MDCSS for each woman in the study based on her address at the time of diagnosis. The 1990 United States Census of Population and Housing Summary Tape File 3A was used to obtain socioeconomic data for census tract. 31 The variables that were used to create SES categories included occupation, poverty status, and educational attainment. Occupation was included because it could serve as a proxy for insurance status, in that most health insurance is obtained through an employer. The 1990 United States Census defined 13 occupational categories; 5 for 'Professional' occupations and 8 for 'Working Class' occupations. We defined SES variables corresponding to census tracts based on the definitions published by Krieger et al. for census block groups. 27 'Working Class' block groups were defined as those in which 66.67% of the population in that census block reported a 'working class' occupation, such as a laborer. 'Professional' groups were those in which 33.33% of employed individuals were in executive or supervisory roles. 'Poor' groups were those in which 20% of the population lived below the poverty level, which was $12,674 for a family of 4 in 1990. 'Educated' groups were those in which 75% of individuals aged 25 years had completed at least a high school education.
Women were assigned to 1 of 8 SES groups, including 1) Working, Poor, Undereducated; 2) Working, Poor, Educated; 3) Working, Nonpoor, Undereducated; 4) Working, Nonpoor, Educated; 5) Professional, Poor, Undereducated; 6) Professional, Poor, Educated; 7) Professional, Nonpoor, Undereducated; and 8) Professional, Nonpoor, Educated. Because there were insufficient numbers for a meaningful analysis in some of the SES groups, the groups were collapsed into 4 mutually exclusive categories as follows: 1) Working, Poor (WP); 2) Working, Nonpoor, Undereducated (WNP-UE); 3) Working, Nonpoor, Educated (WNP-E); and 4) Professional (P).
Statistical Analysis
Chi-square tests were used to compare the demographic characteristics, clinical characteristics, and treatment modalities in AA women and white women. P values <.05 were considered statistically significant. The primary endpoint was overall survival, which was defined as the time from diagnosis to death from any cause. Univariate (unadjusted) analysis of overall survival was performed using KaplanMeier estimates and the log-rank test. Cox proportional hazards regression was used to assess the effect of race on overall survival after adjusting for age at diagnosis (aged <50 years, aged 50 years), marital status (married, other), SES (WP, WNP-UE, WNP-E, P), stage (I, II, III, IV), chemotherapy (none/ refused, chemotherapy/planned), first-course treatment (neither surgery or radiation, surgery only, radiation only, both surgery and radiation), and histology (adenocarcinoma, squamous, adenosquamous). Tumor grade, size, and lymph node status were not included in the multivariable model because of a lack of statistical significance in the univariate analysis and the large proportion of women with missing information. Tumor size information was accounted for in the FIGO staging classification.
RESULTS
There were 705 white women and 331 AA women who were included in the study. The mean age at diagnosis was 51.1 years (standard deviation [SD], 17 years), and the mean age was 52.8 years (SD, 16.7 years) for AA women and 50.4 years (SD, 17.1 years) for white women. The median follow-up was 185 months. Demographic characteristics, clinical characteristics and treatment modalities of the study population stratified by race are shown in Table 1 . There were statistically significant differences in all of the characteristics examined except for tumor grade and lymph node status. AA women were more likely to be older at diagnosis (54.1% diagnosed at age 50 years vs 46.5% of white women; P 5 .02) and were less likely to be married, (26.6% vs 49.9% of white women; P < .001).With regard to SES, AA women were more likely to reside in a census tract categorized as WP (73.1% vs 15.2%), whereas white women were more likely to reside in a census tract designated as P (33% vs 13.9%; P < .001). AA women also were less likely to present at diagnosis with earlier stage disease (48.9% presented with stage I disease vs 59.6% of white women; P < .001) and were more likely to have large tumors at the time of diagnosis (13.9% had tumors that measured >4 cm compared with 6% of white women; P 5 .003). AA women were more likely to have tumors that were of SCC histology (87.9% vs 80.6%; P 5 .01). With regard to treatment, AA women were more likely to have received or planned to receive chemotherapy (26.3% vs 15.9%; P < .001). Treatment with surgery or radiation also differed between the races (P < .001). White women were more likely to undergo surgery only (40.1% vs 27.6%), whereas AA women were more likely to receive radiation only (39.4% vs 30.8%). Slightly more AA women had neither surgery nor radiation (10.9% vs 8.5%).
Survival Analysis
The median survival of women who were diagnosed with invasive cervical cancer in the Detroit Metropolitan area between 1988 and 1992 was 127 months. The unadjusted analyses (data not shown) demonstrated that AA women had a significantly increased risk of death (hazard ratio [HR], 1.49; 95% confidence interval [CI], 1.26-1.76) compared with white women. However, when the multivariable model (Table 2) was adjusted simultaneously for age, marital status, SES, histology, stage, and treatment, race no longer had a significant impact on survival (HR, 1.12; 95% CI, 0.89-1.42). Older women as expected, had an increased risk of death compared with younger women (HR, 2.28; 95% CI, 1.84-2.83). Being married appeared to have a modest negative influence on survival (HR, 1.23; 95% CI, 1.01-1.50). Women from the WP census tract had a modestly higher, but not statistically significant, greater risk of death compared with women from the P census tract (HR, 1.30; 95% CI, 1.00-1.69), and there were no significant differences observed for any of the other census tract groupings (WNP-UE or WNP-E) compared with the P group. Nonsquamous histology (adenocarcinoma or adenosquamous carcinoma) was a significant predictor of worse outcome (adenocarcinoma: HR, 1.89; 95% CI, 1.41-2.54; adenosquamous carcinoma: HR, 2.34; 95% CI, 1.62-3.37). Women who either under- went surgery alone, or received radiation therapy alone, or both underwent surgery and received radiotherapy were more likely to have better survival than women who did not undergo any surgery or receive any radiation, and whether or not women received chemotherapy had no significant impact on survival.
The effect of disease stage on survival appeared to decay over time when women who had stage II, III, or IV disease were compared with women who had stage I disease. After 6 years, the effect of disease stage on overall survival was no longer statistically significant (data not shown).
DISCUSSION
Our univariate analysis demonstrated racial differences in survival, with AA women experiencing worse overall survival compared with white women; however, after simultaneously adjusting for multiple potential confounders, including a proxy measure for SES, race no longer had a significant impact on cervical cancer survival. Several previous studies have evaluated race specifically as a predictor of survival for women with cervical cancer. 4, 5, 7, 8, [32] [33] [34] [35] [36] [37] [38] Four of 10 studies demonstrated that AA women had worse survival compared with white women despite adjustment for several potential confounder variables, 5, 8, 32, 36 whereas 6 of 10 studies showed no racial differences in survival after multivariate adjustment. 4, [33] [34] [35] 37, 38 Thoms et al. 34 reported no survival differences between AA women and white women after adjustment for stage, age and histology. However in their study, 127 women (80%) were AA, and the small number of white women may have limited the power of the study to evaluate survival differences by race. Grigsby et al. 33 evaluated 922 women (207 AA women and 715 white women) at the Mallinckrodt Institute of Radiology with either stage II or stage III disease who received radiation therapy and observed no racial difference in cancer-specific survival. However, the 5-year overall survival rate for patients who were diagnosed with stage II disease was significantly less for AA women compared with white women (51% vs 60%, respectively; P 5 .02). This difference in survival was attributed to other noncancer-related factors. 33 In our study, factors that were associated with poor survival included advanced stage at presentation, lack of appropriate surgery, being married, nonsquamous histology, and increasing age. Several reports have demonstrated that AA women have worse survival secondary to presenting at a later stage of disease. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] According to our data, white women were more likely to present with stage I disease than AA women. Eggleston et al. 7 studied 7237 women with cervical cancer in the Texas Cancer Registry from 1995 to 2001. Disease stage in that study was categorized as early stage (IA1, IA2, or IB) and late stage (II, III, IV). Consistent with our results, AA women were more likely to be diagnosed with latestage disease (47.3%) than non-Hispanic white women (37.1%). A cervical cancer-specific survival analysis demonstrated that women who were diagnosed at a later stage were 6.2 times more likely to die within 80 months than women who were diagnosed at an early stage and that AA women were 1.3 times more likely to die than white women.
Treatment disparities between AA women and white women also have been evaluated in several studies. 4, 5, 8, 10, 14, 15 In our study, a slightly greater percentage of AA women compared with white women did not receive either surgery or radiation. Our popu- lation of AA women was older than the white population. Consistent with our results, many studies have demonstrated that increasing age is associated with worsening survival among women with cervical cancer. 8, 16, 17, 20, 21, [38] [39] [40] Older women may use screening less often and may present at a later stage; thus, they may have lower survival rates. Other explanations include the possibility that older patients are more likely to refuse treatment or to have comorbid conditions that preclude standard cancer treatment. 41 Mundt et al. 14 demonstrated that AA women with locally advanced disease were less likely to receive intracavitary radiation therapy (ICRT) than white women (13% vs 4%; P 5 .07). This was attributed either to technical problems in placing the ICRT or to the greater prevalence of other comorbid health conditions in the AA women. In both the study by Mundt et al. and our study, receipt of radiation therapy was associated with better survival compared with no therapy.
Studies on histology and survival have demonstrated worsening survival for women who have nonsquamous histology compared with women who have squamous histology, 16, 23, 34, 38, 42 consistent with our results. It has been postulated that this is because nonsquamous cancers are not detected as easily on Papanicolaou smears. It is noteworthy that, in the Cancer Prevention and Control Surveillance Program study, of 17,119 women evaluated, there were no statistically significant differences in 5-year relative survival rates between women with adenocarcinoma and women with SCC. However, when comparing survival rates for adenosquamous carcinoma with the rates for SCC, the 5-year relative survival was 54.9% for adenosquamous and 67.2% for SCC (P 5 .05). 38 The literature examining marital status and cervical cancer survival is scant. In the report by Murphy et al., 19 >1000 women from the South Thames Cancer Registry were classified as single, married, widowed, or divorced. That study indicated that, after adjustment for age, there were no significant differences in survival according to marital status. Our study indicated that being married tended to have a modest negative influence on survival, although we have no reasonable explanation for that finding.
The strengths of our study include the large population size, the long period of follow-up, and the use of SES on a census tract level. In articles that examined cervical cancer survival and SES, 6, 7, 14, [16] [17] [18] [19] [20] [21] [22] [23] 6 of 11 studies indicated that women with lower SES had poorer survival. 6, 7, 17, [20] [21] [22] Eggleston et al. 7 reported on 5467 women with cervical cancer. In their study, an SES variable was defined by using measures of employment, income, education, and poverty at the zip code level. After adjusting for stage, lower SES was associated with poorer survival (HR, 1.9; 95% CI, 1.6-2.3; P < .001). In their report, AA race still was associated with poorer survival after adjusting for SES (HR, 1.3; 95% CI, 1.1-1.5). In the study by Greenwald et al., 18 race was associated independently with survival, but SES was not. In that study, SES was based on the percentage of high school graduates among individuals aged 25 years in each zip code area. Race continued to predict mortality after adjusting for SES, although using education alone as a proxy for SES, especially in a large geographic area, may have not been an adequate method for estimating SES. In fact, SES has not been defined consistently in the literature, which may explain in part the variability in the reported results.
However, there are inherent problems in using the SEER registry for data collection. All data are collected from medical records and are only as complete or accurate as the original medical record. An evaluation of racial classification in the Detroit SEER registry revealed that AAs were 4 times more likely to be misclassified with regard to their race than whites, although the agreement between self-reported race and registry race was 99.7%. 43 Another potential problem is that we used overall survival as an outcome rather than cancer-specific survival, because the cause of death variable derived from death certificate information is prone to misclassification. 44, 45 In addition, differences in overall survival between AA women and white women may be related to a higher prevalence of comorbid conditions among AA women, data that are not collected in the SEER database. Some studies have evaluated the impact of comorbid conditions on cervical cancer survival, including the level of pretreatment hemoglobin during cancer-directed therapy to explain racial differences in cervical cancer survival 14, 15, 46 ; however, further work needs to be done to evaluate the impact of other comorbid conditions on survival. There also are potential biologic differences in tumor aggressiveness and response to treatment between AA women and white women that should be evaluated further, because they may explain survival differences.
The current study adds to the existing literature on racial differences in cervical cancer using a population-based source of data. In addition, it offers a more refined method for studying racial differences in survival in the context of SES. Our results demonstrate that poor survival in AA women is explained at least in part by low SES as well as by other variables that have a potential impact on access to care. It is important for policy makers to improve access to early screening, early detection, and treatment opportunities to reduce and eventually, not only eliminating discrepancies in stage at presentation but also resulting in more equitable survival for all women who are diagnosed with cervical cancer. Furthermore, clinicians must remind women beyond their childbearing years of the importance of continuing to screen for cervical cancer.
